3,005 followers
New Research: Risk of transient vision loss after intravitreal aflibercept using vial-prepared vs. the novel prefilled syringe formulation: Purpose To compare the risk of transient vision loss (TVL) probably… https://t.co/Snx0s2Em1X #medicalcare #clinical